FOXO3 regulates CD8 T cell memory by T cell-intrinsic mechanisms

PLoS Pathogens

Volumn 8, Issue 2, 2012, Pages

  Sullivan, Jeremy A ^a   Kim, Eui Ho ^a   Plisch, Erin H ^a   Peng, Stanford L ^b   Suresh, M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHRL1; FORKHEAD TRANSCRIPTION FACTOR; FOXO3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL DIVISION; CELL EXPANSION; CELL VIABILITY; CONTROLLED STUDY; EFFECTOR CELL; ENZYME PHOSPHORYLATION; HOMEOSTASIS; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; SPLEEN; VIRUS INFECTION; ANIMAL; ARENAVIRUS INFECTION; C57BL MOUSE; CELL SEPARATION; FLOW CYTOMETRY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MUS;

ANIMALS; ARENAVIRIDAE INFECTIONS; BLOTTING, WESTERN; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOLOGIC MEMORY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION;

EID: 84860898727     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002533     Document Type: Article

References (74)

1. Jameson SC, Masopust D, (2009) Diversity in T cell memory: An embarrassment of riches. Immunity 31: 859-871.
2. Pulendran B, Ahmed R, (2011) Immunological mechanisms of vaccination. Nat Immunol 12: 509-517.
3. Pulendran B, Ahmed R, (2006) Translating innate immunity into immunological memory: Implications for vaccine development. Cell 124: 849-863.
4. Sallusto F, Lanzavecchia A, Araki K, Ahmed R, (2010) From vaccines to memory and back. Immunity 33: 451-463.
5. Ahmed R, Gray D, (1996) Immunological memory and protective immunity: Understanding their relation. Science 272: 54-60.
6. Kaech SM, Ahmed R, (2003) Immunology. CD8 T cells remember with a little help. Science 300: 263-265.
7. Kalia V, Sarkar S, Ahmed R, (2010) CD8 T-cell memory differentiation during acute and chronic viral infections. Adv Exp Med Biol 684: 79-95.
8. Sprent J, Surh CD, (2011) Normal T cell homeostasis: The conversion of naive cells into memory-phenotype cells. Nat Immunol 12: 478-484.
9. Barber GN, (2001) Host defense, viruses and apoptosis. Cell Death Differ 8: 113-126.
10. Gourley TS, Wherry EJ, Masopust D, Ahmed R, (2004) Generation and maintenance of immunological memory. Semin Immunol 16: 323-333.
11. Hand TW, Morre M, Kaech SM, (2007) Expression of IL-7 receptor alpha is necessary but not sufficient for the formation of memory CD8 T cells during viral infection. Proc Natl Acad Sci U S A 104: 11730-11735.
12. Masopust D, Murali-Krishna K, Ahmed R, (2007) Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: It is even bigger than we thought. J Virol 81: 2002-2011.
13. Hand TW, Kaech SM, (2009) Intrinsic and extrinsic control of effector T cell survival and memory T cell development. Immunol Res 45: 46-61.
14. Haring JS, Badovinac VP, Harty JT, (2006) Inflaming the CD8+ T cell response. Immunity 25: 19-29.
15. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJD, Zajac AJ, et al. (1998) Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 8: 177-187.
16. Joshi NS, Cui W, Chandele A, Lee HK, Urso DR, et al. (2007) Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor. Immunity 27: 281-295.
17. Sarkar S, Kalia V, Haining WN, Konieczny BT, Subramaniam S, et al. (2008) Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J Exp Med 205: 625-640.
18. Burgering BM, Kops GJ, (2002) Cell cycle and death control: Long live forkheads. Trends Biochem Sci 27: 352-360.
19. Castrillon DH, Miao L, Kollipara R, Horner JW, DePinho RA, (2003) Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301: 215-218.
20. Neufeld TP, (2003) Shrinkage control: Regulation of insulin-mediated growth by FOXO transcription factors. J Biol 2: 18.
21. Accili D, Arden KC, (2004) FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117: 421-426.
22. Hosaka T, Biggs WH 3rd, Tieu D, Boyer AD, Varki NM, et al. (2004) Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci U S A 101: 2975-2980.
23. Barthel A, Schmoll D, Unterman TG, (2005) FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab 16: 183-189.
24. Peng SL, (2008) Foxo in the immune system. Oncogene 27: 2337-2344.
25. van der Vos KE, Coffer PJ, (2008) FOXO-binding partners: It takes two to tango. Oncogene 27: 2289-2299.
26. van der Vos KE, Coffer PJ, (2011) The extending network of FOXO transcriptional target genes. Antioxid Redox Signal 14: 579-592.
27. Jacobs FM, van der Heide LP, Wijchers PJ, Burbach JP, Hoekman MF, et al. (2003) FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. J Biol Chem 278: 35959-35967.
28. Calnan DR, Brunet A, (2008) The FoxO code. Oncogene 27: 2276-2288.
29. Biggs WH 3rd, Meisenhelder J, Hunter T, Cavenee WK, Arden KC, (1999) Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci U S A 96: 7421-7426.
30. Kops GJPL, Medema RH, Glassford J, Essers MAG, Dijkers PF, et al. (2002) Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol 22: 2025-2036.
31. Van Der Heide LP, Hoekman MF, Smidt MP, (2004) The ins and outs of FoxO shuttling: Mechanisms of FoxO translocation and transcriptional regulation. Biochem J 380: 297-309.
32. Strasser A, Harris AW, Huang DC, Krammer PH, Cory S, (1995) Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 14: 6136-6147.
33. Bouillet P, Metcalf D, Huang DCS, Tarlinton DM, Kay TWH, et al. (1999) Proapoptotic bcl-2 relative bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286: 1735-1738.
34. Dijkers PF, Medema RH, Lammers JW, Koenderman L, Coffer PJ, (2000) Expression of the pro-apoptotic bcl-2 family member bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 10: 1201-1204.
35. Dijkers PF, Medema RH, Pals C, Banerji L, Thomas NSB, et al. (2000) Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27KIP1. Mol Cell Biol 20: 9138-9148.
36. Grayson JM, Zajac AJ, Altman JD, Ahmed R, (2000) Cutting edge: Increased expression of bcl-2 in antigen-specific memory CD8+ T cells. J Immunol 164: 3950-3954.
37. Sharpless NE, DePinho RA, (2002) P53: Good Cop/bad cop. Cell 110: 9-12.
38. Stahl M, Dijkers PF, Kops GJ, Lens SM, Coffer PJ, et al. (2002) The forkhead transcription factor FoxO regulates transcription of p27Kip1 and bim in response to IL-2. J Immunol 168: 5024-5031.
39. Wan J, Martinvalet D, Ji X, Lois C, Kaech SM, et al. (2003) The bcl-2 family pro-apoptotic molecule, BNIP3 regulates activation-induced cell death of effector cytotoxic T lymphocytes. Immunology 110: 10-17.
40. Lin L, Hron JD, Peng SL, (2004) Regulation of NF-kappaB, th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21: 203-213.
41. Tait ED, Hunter CA, (2009) The foxo and the hound: Chasing the in vivo regulation of T cell populations during infection. Nat Immunol 10: 457-458.
42. Zhou W, Cao Q, Peng Y, Zhang QJ, Castrillon DH, et al. (2009) FoxO4 inhibits NF-kappaB and protects mice against colonic injury and inflammation. Gastroenterology 137: 1403-1414.
43. Singh A, Jatzek A, Plisch EH, Srinivasan R, Svaren J, et al. (2010) Regulation of memory CD8 T-cell differentiation by cyclin-dependent kinase inhibitor p27Kip1. Mol Cell Biol 30: 5145-5159.
44. Dijkers PF, Birkenkamp KU, Lam EW, Thomas NS, Lammers JW, et al. (2002) FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal. J Cell Biol 156: 531-542.
45. Martinez-Gac L, Alvarez B, Garcia Z, Marques M, Arrizabalaga M, et al. (2004) Phosphoinositide 3-kinase and forkhead, a switch for cell division. Biochem Soc Trans 32: 360-361.
46. Birkenkamp KU, Coffer PJ, (2003) FOXO transcription factors as regulators of immune homeostasis: Molecules to die for? J Immunol 171: 1623-1629.
47. Peng SL, (2007) Immune regulation by foxo transcription factors. Autoimmunity 40: 462-469.
48. Riou C, Yassine-Diab B, Van grevenynghe J, Somogyi R, Greller LD, et al. (2007) Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells. J Exp Med 204: 79-91.
49. Dejean AS, Beisner DR, Ch'en IL, Kerdiles YM, Babour A, et al. (2009) Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells. Nat Immunol 10: 504-513.
50. Hedrick SM, (2009) The cunning little vixen: Foxo and the cycle of life and death. Nat Immunol 10: 1057-1063.
51. Ohkura N, Sakaguchi S, (2010) Foxo1 and Foxo3 help Foxp3. Immunity 33: 835-837.
52. Dejean AS, Hedrick SM, Kerdiles YM, (2011) Highly specialized role of forkhead box O transcription factors in the immune system. Antioxid Redox Signal 14: 663-674.
53. Ouyang W, Li MO, (2011) Foxo: In command of T lymphocyte homeostasis and tolerance. Trends Immunol 32: 26-33.
54. Kerdiles YM, Beisner DR, Tinoco R, Dejean AS, Castrillon DH, et al. (2009) Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat Immunol 10: 176-184.
55. Coffer PJ, Burgering BM, (2004) Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol 4: 889-899.
56. Barata JT, Silva A, Brandao JG, Nadler LM, Cardoso AA, et al. (2004) Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. J Exp Med 200: 659-669.
57. Finlay D, Cantrell D, (2010) Phosphoinositide 3-kinase and the mammalian target of rapamycin pathways control T cell migration. Ann N Y Acad Sci 1183: 149-157.
58. Suresh M, Lanier G, Large MK, Whitmire JK, Altman JD, et al. (2002) Role of lymphotoxin alpha in T-cell responses during an acute viral infection. J Virol 76: 3943-3951.
59. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, et al. (2003) Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4: 225-234.
60. Hand TW, Cui W, Jung YW, Sefik E, Joshi NS, et al. (2010) Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival. Proc Natl Acad Sci U S A 107: 16601-16606.
61. Sanjabi S, Mosaheb MM, Flavell RA, (2009) Opposing effects of TGF-β and IL-15 cytokines control the number of short-lived effector CD8+ T cells. Immunity 31: 131-144.
62. Ahmed MB, Belhadj Hmida N, Moes N, Buyse S, Abdeladhim M, et al. (2009) IL-15 renders conventional lymphocytes resistant to suppressive functions of regulatory T cells through activation of the phosphatidylinositol 3-kinase pathway. J Immunol 182: 6763-6770.
63. Wojciechowski S, Tripathi P, Bourdeau T, Acero L, Grimes HL, et al. (2007) Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis. J Exp Med 204: 1665-1675.
64. Weant AE, Michalek RD, Khan IU, Holbrook BC, Willingham MC, et al. (2008) Apoptosis regulators bim and fas function concurrently to control autoimmunity and CD8+ T cell contraction. Immunity 28: 218-230.
65. Kurtulus S, Tripathi P, Moreno-Fernandez ME, Sholl A, Katz JD, et al. (2011) Bcl-2 allows effector and memory CD8+ T cells to tolerate higher expression of bim. J Immunol 186: 5729-5737.
66. Zhang X, Sun S, Hwang I, Tough DF, Sprent J, (1998) Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8: 591-599.
67. Becker TC, Wherry EJ, Boone D, Murali-Krishna K, Antia R, et al. (2002) Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med 195: 1541-1548.
68. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, et al. (2003) Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 4: 1191-1198.
69. Paik J, Kollipara R, Chu G, Ji H, Xiao Y, et al. (2007) FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128: 309-323.
70. Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, et al. (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128: 325-339.
71. Harada Y, Harada Y, Elly C, Ying G, Paik JH, et al. (2010) Transcription factors Foxo3a and Foxo1 couple the E3 ligase cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J Exp Med 207: 1381-1391.
72. Ouyang W, Beckett O, Ma Q, Paik JH, DePinho RA, et al. (2010) Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol 11: 618-627.
73. van Grevenynghe J, Procopio FA, He Z, Chomont N, Riou C, et al. (2008) Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection. Nat Med 14: 266-274.
74. Ahmed R, Salmi A, Butler LD, Chiller JM, Oldstone MB, (1984) Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med 160: 521-540.